Francine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, Sabeha Biichle, Franck Trimoreau, Estelle Seilles, Véronique Salaun, Richard Garand, Pascale Lepelley, Marc Maynadié, Emilienne Kuhlein, Eric Deconinck, Sylvie Daliphard, Laurence Chaperot, Lucille Beseggio, Vincent Foisseaud, Elizabeth Macintyre, Marie-Christine Bene, Philippe Saas, Marie-Christine Jacob
The diagnosis of plasmacytoid dendritic cell leukaemia (pDCL) is based on the immunophenotypic profile: CD4(+) CD56(+) lineage(neg) CD45RA(+)/RO(neg) CD11c(neg) CD116(low) CD123(+) CD34(neg) CD36(+) HLA-DR(+). Several studies have reported pDCL cases that do not express this exact profile or expressing some lineage antigens that could thus be misdiagnosed. This study aimed to validate pDCL-specific markers for diagnosis by flow-cytometry or quantitative reverse transcription polymerase chain reaction on bone marrow samples...
June 2009: British Journal of Haematology